Skip to main content

Table 2 Role of pH in plasma on inter-conversion (n = 4)

From: Stability indicating LC-MS/MS method for estimation of lovastatin in human plasma: application to a bioequivalence study

Analysis of LS spiked sample (10.0 ng/mL)

Duration

Normal plasma

Acidified plasma (pH 6.0)

Acidified plasma (pH 4.0)

A1

A2

A1

A2

A1

A2

0.0 h

588,767

14,529

722,551

2157

621,396

2548

2.0 h

565,406

21,013

718,763

2478

632,705

2989

4.0 h

533,753

25,785

729,776

2054

634,905

3054

6.0 h

482,788

27,854

716,005

2248

604,583

2689

Analysis of LHA spiked sample (10.0 ng/mL)

Duration

Normal plasma

Acidified plasma (pH 6.0)

Acidified plasma (pH 4.0)

A1

A2

A1

A2

A1

A2

0.0 h

9642

37,598

2034

46,998

6556

43,560

2.0 h

13,925

33,423

2496

42,578

10,026

40,527

4.0 h

16,780

33,168

2738

42,895

11,947

38,952

6.0 h

19,962

31,313

2568

44,224

15,890

34,744

  1. A1 mean peak area observed at RT of LS (m/z: 422.1 → 285.4), A2 mean peak area observed at RT of LHA (m/z:423.3 → 303.7) both in positive ion mode